Soleus Capital Management »

Protagonist Therapeutics shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.9M 83k 22.93
2023-06-30 $1.1M 40k 27.62
2022-12-31 $2.6M 236k 10.91